NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/08/2026
Voltar para busca
Dado oficial do USPTO
BIMAKE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BIMAKE
ST13
US500000087035040Classe
1, 5, 9, 10
Pedido
87035040
Registro
6042794
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
64
Atualização mais recente
04/08/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10
Data de depósito
12/05/2016
Data de registro
28/04/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/08/2026
Última transação
04/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
705
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/12/2017
Primeiro uso no comércio
01/12/2017
Código do desenho
4
Tipo de titular
01
Localização do titular
Houston, TX, CN
Examinador
WOOD, CAROLINE
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
D. D. (pessoa física)
Representantes
Mark R. Backofen Troutman Pepper Locke LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry; biochemicals for use in industry for nonmedical purposes; Reagents for scientific and research usehot start high-fidelity DNA polymerasepolymerase chain reaction reagent (PCR) master mixpolymerase chain reaction reagentsone step synthesized complimentary DNA (cDNA) synthesis master mixquantitative polymerase chain reaction reagent (qPCR) master mixesproteinase inhibitorscell viability assayDNA transfection reagents for scientific and research use; nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes
Classe 5
Reagents for medical usehot start high-fidelity DNA polymerasepolymerase chain reaction reagent (PCR) master mixespolymerase chain reaction reagentsone step synthesized complimentary DNA (cDNA) synthesis master mixesquantitative polymerase chain reaction reagent (qPCR) master mixesproteinase inhibitorscell viability assaysDNA transfection reagent; nucleic acid isolation and purification kit consisting primarily of reagents for medical use
Classe 9
Laboratory instrumentsDNA Microfluidic chip systems comprised of disk-electrophoresis readermulti-lane electrophoresis chipliquid DNA separation gelloading buffer for DNADNA markers; RNA Microfluidic chip systems comprised of disk-electrophoresis readermulti-lane electrophoresis chipliquid RNA separation gelloading buffer for RNARNA markers; Protein Microfluidic chip systems comprised of disk-electrophoresis readermulti-lane electrophoresis chipliquid PRO separation gelloading buffer for proteinprotein markers; Automated Microfluidic electrophoresis chip for Western Blotting; Bioanalyzer apparatus for analyzing protein-protein and protein-small molecule interaction; Electroporator for applying an electrical field to cells to increase the permeability of the cell membranefor introduction of chemicalsdrugsDNA; Automated Microfluidic chip system comprised of multi-lane electrophoresis chipdisk- electrophoresis readerseparation gelloading buffer and markers for molecular cloning and transformation
Classe 10
Medical and diagnostic apparatusDNA microfluidic chip systems comprised of multi-lane electrophoresis chipdisk-electrophoresis readerliquid DNA separation gelloading buffer for DNADNA markers for testing DNARNA microfluidic chip systems comprised of multi-lane electrophoresis chipdisk-electrophoresis readerliquid RNA separation gelloading buffer for RNARNA markers for testing RNA all for medical diagnostic use; medical and diagnostic apparatusprotein microfluidic chip systems comprised of multi-lane electrophoresis chipdisk-electrophoresis readerliquid PRO separation gelloading buffer for proteinprotein markers for testing proteinsautomated microfluidic electrophoresis chip for western blottingall for medical diagnostic use
Publicações
Histórico de despachos e eventos da marca no USPTO.
64 publicações encontradas
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/08/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/07/2026
E815
TEAS SECTION 8 & 15 RECEIVED
27/04/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/11/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/11/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/11/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28/04/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
28/04/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
27/03/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
26/03/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/03/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/03/2020
EX4G
SOU EXTENSION 4 GRANTED
06/03/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/03/2020
IUAF
USE AMENDMENT FILED
27/02/2020
EXT4
SOU EXTENSION 4 FILED
27/02/2020
EEXT
SOU TEAS EXTENSION RECEIVED
27/02/2020
EISU
TEAS STATEMENT OF USE RECEIVED
27/02/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
22/08/2019
EX3G
SOU EXTENSION 3 GRANTED
19/08/2019
EXT3
SOU EXTENSION 3 FILED
19/08/2019
EEXT
SOU TEAS EXTENSION RECEIVED
19/08/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/01/2019
EX2G
SOU EXTENSION 2 GRANTED
25/01/2019
EXT2
SOU EXTENSION 2 FILED
25/01/2019
EEXT
SOU TEAS EXTENSION RECEIVED
25/01/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
29/08/2018
EX1G
SOU EXTENSION 1 GRANTED
27/08/2018
EXT1
SOU EXTENSION 1 FILED
27/08/2018
EEXT
SOU TEAS EXTENSION RECEIVED
27/08/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
27/02/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/01/2018
PUBO
PUBLISHED FOR OPPOSITION
02/01/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
13/12/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/11/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
28/11/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
28/11/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
28/11/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
28/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/11/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
07/11/2017
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
10/10/2017
GNCF
CONTINUATION OF FINAL REFUSAL E-MAILED
10/10/2017
CNCF
ACTION CONTINUING A FINAL - COMPLETED
10/10/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/09/2017
ALIE
ASSIGNED TO LIE
13/09/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/09/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
10/03/2017
GNFR
FINAL REFUSAL E-MAILED
10/03/2017
CNFR
FINAL REFUSAL WRITTEN
10/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/02/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/09/2016
GNRT
NON-FINAL ACTION E-MAILED
06/09/2016
CNRT
NON-FINAL ACTION WRITTEN
06/09/2016
DOCK
ASSIGNED TO EXAMINER
29/08/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/05/2016
NWAP
NEW APPLICATION ENTERED
16/05/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIMAKE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.